tirzepatide pulled from market The FDA says the Zepbound shortage is over. That's rattling the weight loss industry Tirzepatide is the #1 weight

Here are the key findings from several significant studies: 1

Mar 23, 2026 Some researchers draw 50 units and barely feel a thing

Percentage of body weight lost at 72 weeks in the 15 mg tirzepatide group was 22.6% for those with disease duration of 10 years or less, 22.9% with 10 to 20 years duration, and 22.1% for more than 20 years disease duration

Bunck, M.D., Ph.D., and Adam Stefanski, M.D., Ph.D., for the SURMOUNT-1 Investigators* Relevant Literature SURMOUNT-1 Trial Relevant Guidelines -SURMOUNT-1 Trial Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guidelines (2015) Drugs may amplify adherence to behavior change and improve physical functioning such that increased physical activity is easier for those who cannot exercise initially

One prospective study of low-risk individuals, looking at the heart, lungs, liver, kidneys, pancreas and spleen, noted that 70% of 201 patients had damage to at least one organ and 29% had multi-organ damage 69

Those without insurance coverage, will have to pay $399 (2.5mg) for single-dose vials, or $549 (5mg) for a months supply through LillyDirects self-pay pharmacy